薄芝糖肽臨床應(yīng)用中文文獻(xiàn)分析
發(fā)布時(shí)間:2018-05-22 15:51
本文選題:薄芝糖肽 + 臨床應(yīng)用 ; 參考:《中國(guó)藥師》2016年06期
【摘要】:目的:分析薄芝糖肽臨床應(yīng)用情況,為臨床合理用藥提供參考。方法:檢索相關(guān)期刊論文(CNKI)、萬(wàn)方數(shù)據(jù)庫(kù)、維普資訊網(wǎng)(VIP)收錄的薄芝糖肽相關(guān)文獻(xiàn),對(duì)薄芝糖肽主要臨床應(yīng)用(同病種文獻(xiàn)發(fā)表數(shù)量大于3篇)及不良反應(yīng)進(jìn)行統(tǒng)計(jì)和分析。結(jié)果:檢索得文獻(xiàn)163篇,包含臨床應(yīng)用文獻(xiàn)137篇,其中文獻(xiàn)發(fā)表數(shù)大于3篇的病種有尖銳濕疣(9篇)、帶狀皰疹(6篇)、手足口病(6篇)、尋常型銀屑病(6篇)、肺癌(5篇)、小兒反復(fù)呼吸道感染(4篇)、乙型肝炎(9篇),共計(jì)45篇。45篇臨床應(yīng)用文獻(xiàn)中有32篇(共1 772例)涉及不良反應(yīng)病例,有49例發(fā)生不良反應(yīng),發(fā)生率為2.77%,以皮膚及其附件損害為主(10例,20.0%)。ADR病例報(bào)道11篇,涉及病例數(shù)20例,以寒戰(zhàn)和發(fā)熱為主(13例,37.2%)。結(jié)論:薄芝糖肽作為輔助用藥在臨床上主要與其他藥物聯(lián)合應(yīng)用,能夠增強(qiáng)主要治療藥物的療效,不良反應(yīng)發(fā)生率低且以皮膚及其附件損害為主。
[Abstract]:Objective: to analyze the clinical application of Ganoderma lucidum glycopeptide in order to provide reference for rational drug use. Methods: to search the related documents of Ganoderma lucidum glycopeptide included in CNKI, Wanfang database, Weipu Web site and VIPs. The main clinical application of Glucoderma lucidum glycopeptide (more than 3 articles published in the same disease literature) and adverse reactions were analyzed. Results: 163 articles were retrieved, including 137 articles of clinical application. Among them, more than 3 articles were published on the following diseases: condyloma acuminatum (9), herpes zoster (6), hand, foot and mouth (6), psoriasis vulgaris (6), lung cancer (5), recurrent respiratory tract infection in children (4), hepatitis B (9). Among 45 articles of clinical application, 32 (1 772 cases) involved adverse reactions. There were 49 cases of adverse reactions (2.77%), 10 cases were mainly skin and adnexal lesions, 11 cases were reported, 20 cases were involved, 13 cases were chills and fever. Conclusion: Ganoderma lucidum glycopeptide as an adjuvant drug can be combined with other drugs in clinic, which can enhance the efficacy of the main therapeutic drugs. The incidence of adverse reactions is low and the damage to skin and its appendages is the main adverse reaction.
【作者單位】: 山西醫(yī)科大學(xué)藥學(xué)院;山西醫(yī)科大學(xué)第一醫(yī)院藥劑科;
【分類號(hào)】:R977
【相似文獻(xiàn)】
相關(guān)期刊論文 前8條
1 魁學(xué)梅;朱宗杰;付松泉;;薄芝糖肽注射液致全身疼痛、高熱1例[J];中國(guó)藥事;2014年04期
2 李柏剛;曲會(huì)君;張雪;;薄芝糖肽預(yù)防抗結(jié)核藥物肝損害的臨床觀察[J];醫(yī)藥導(dǎo)報(bào);2010年03期
3 歐志堅(jiān);;薄芝糖肽注射液引起高熱、嘔吐1例[J];中國(guó)藥物警戒;2013年10期
4 丁蘇蘇;李倚云;董登存;;薄芝糖肽注射液細(xì)菌內(nèi)毒素檢查法可行性研究[J];海峽藥學(xué);2009年11期
5 徐秀;李雪;;薄芝糖肽注射液發(fā)生過(guò)敏性反應(yīng)1例報(bào)告[J];齊齊哈爾醫(yī)學(xué)院學(xué)報(bào);2009年07期
6 劉淑梅;劉麗華;賈季梅;王鳳榮;郭志慧;;靜點(diǎn)薄芝糖肽發(fā)生過(guò)敏性反應(yīng)2例報(bào)告[J];醫(yī)學(xué)理論與實(shí)踐;2008年08期
7 李雪靜;;薄芝糖肽注射劑致過(guò)敏反應(yīng)1例[J];中國(guó)臨床藥學(xué)雜志;2011年04期
8 ;[J];;年期
,本文編號(hào):1922703
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/1922703.html
最近更新
教材專著